Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 752-764

  Di Ianni, Mauro ^a   Del Papa, Beatrice ^a   De Ioanni, Maria ^a   Terenzi, Adelmo ^a   Sportoletti, Paolo ^a   Moretti, Lorenzo ^a   Falzetti, Franca ^a   Gaozza, Eugenia ^a   Zei, Tiziana ^a   Spinozzi, Fabrizio ^a   Bagnis, Claude ^b   Mannoni, Patrice ^b   Bonifacio, Elisabetta ^a   Falini, Brunangelo ^a   Martelli, Massimo F ^a   Tabilio, Antonio ^a,c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c POLICLINICO MONTELUCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 7; RECOMBINANT INTERLEUKIN 7; RETROVIRUS VECTOR; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CELL COUNT; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; SPLEEN; STROMA CELL; T CELL DEPLETION; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL TRANSPLANTATION; GENETIC ENGINEERING; HUMANS; INTERLEUKIN-7; MICE; MICE, INBRED NOD; MICE, SCID; RETROVIRIDAE; STROMAL CELLS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

MURINAE;

EID: 20844448230     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.752     Document Type: Article

References (60)

1. ABDUL-HAI, A., OR, R., SLAVIN, S., FRIEDMAN, G., WEISS, L., MATSA, D., and BEN-YEHUDA, A. (1996). Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp. Hematol. 24, 1416-1422.
2. ALLAY, J.A., DENNIS, J.E., HAYNESWORTH, S.E., MAJUMDAR, M.K., CLAPP, D.W., SHULTZ, L.D., CAPLAN, A.I., and GERSON, S.L. (1997). LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 8, 1417-1427.
3. ALPDOGAN, O., SCHMALTZ, C., MURIGLAN, S.J., KAPPEL, B., PERALES, M.A., ROTOLO, J.A., HALM, J.A., RICH, B.E., and VAN DEN BRINK, M.R.M. (2001). Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98, 2256-2265.
4. ALPDOGAN, O., MURIGLAN, S.J., ENG, J.M., WILLIS, L.M., GREENBERG, A.S., RAPPEL, B.J., and VAN DER BRINK, M.R.M. (2003). IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112, 1095-1107.
5. ANKLESARIA, P., FITZGERALD, T.J., KASE, K., OHARA, A., and GREENBERGER, J.S. (1989). Improved hematopoiesis in anemic SI/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment. Blood 74, 1144-1151.
6. BANWELL, C.M., PARKINGTON, K.M., JENKINSON, E.J., and ANDERSON, G. (2000) Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur. J. Immunol. 20, 2125-2129.
7. BARDA-SAAD, M., ROZENSZAJN, L.A., GLOBERSON, A., ZHANG, A.S., and ZIPORI, D. (1996). Selective adhesion of immature thymocytes to bone marrow stromal cells: Relevance to T cell lymphopoiesis. Exp. Hematol. 24, 386-391.
8. BARTHOLOMEW, A., PATIL, S., MACKAY, A., NELSON, M., BUYANER, D., HARDY, W., MOSCA, J., STURGEON, C., SIATSKAS, M., MAHMUD, N., FERRER, K., DEANS, R., MOSELEY, A., HOFFMAN, R., and DEVINE, S.M. (2001). Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 12, 1527-1541.
9. BENSIDHOUM, M., LAROU, M., LE MEUR, M., DIERICH, A., COSTET, P., RAYMOND, S., DANIEL, J.Y., VERNEUIL, H., and GED, C. (1998). The disruption of mouse uroporphyrinogen III synthase (uros) gene is fully lethal. Transgenics 2, 275-280.
10. + human mesenchymal stem cells into the NOD-SCID mouse: Their role in supporting human CD34 cell engraftment. Blood 103, 3313-3319.
11. BOLOTIN, E., SMOGORZEWSKA, M., SMITH, S., WIDMER, M., and WEINBERG, K. (1996). Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88, 1887-1894.
12. BOLOTIN, E., ANNETT, G., PARKMAN, R., and WEINBERG, K. (1999). Serum levels of IL-7 in bone marrow transplant recipients: Relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant. 23, 783-788.
13. BROERS, A.E., POSTHUMUS-VAN SLUJIS, S.J., SPITS, H., VAN DER HOLT, B., LOWEMBERG, B., BRAAKMAN, E., and CORNELISSEN, J.J. (2003). Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 102, 1534-1540.
14. CARLO-STELLA, C., TABILIO, A., RAGAZZI, E., GARAU, D., LA TAGLIATA, R., TRASARTI, S., ANDRIZZI, C., VIGNETTI, M., and MELONI, G. (1997). Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant. 20, 465-471.
15. CILLONI, D., CARLO-STELLA, C., FALZETTI, F., SAMMARELLI, G., REGAZZI, E., COLLA, S., RIZZOLI, V., AVERSA, F., MARTELLI, M.F., and TABILIO, A. (2000). Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 96, 3637-3643.
16. CORDELL, J.L., FALINI, B., and ERBER, W.N. (1984). Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32, 219-229.
17. + T cells. Proc. Natl. Acad. Sci. U.S.A. 98, 9277-9282.
18. DEANS, R.J., and MOSELEY, A.B. (2000). Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28, 875-884.
19. DEVINE, S.M., COBBS, C. JENNINGS, M., BARTHOLOMEW, A., and HOFFMAN, R. (2003). Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101, 2999-3001.
20. DEXTER, T.M. (1989). Regulation of hemopoietic cell growth and development: Experimental and clinical studies. Leukemia 3, 469-474.
21. DI IANNI, M., CASCIARI, C., CIURNELLI, R., FULVI, A., BAGNIS, C., LUCHERONI, F., FALZETTI, F., MANNONI, P., MARTELLI, M.F., and TABILIO, A. (1996). β-Galactosidase transduced T lymphocytes: A comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. Haematologica 81, 410-417.
22. DI NICOLA, M., CARLO-STELLA, C., MAGNI, M., MILANESI, M., and LONGONT, P.D. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843.
23. FRY, T.J., and MACKALL, C.L. (2002). Interleukin 7: From bench to clinic. Blood 99, 3892-3904.
24. FRY, T.J., CONNICK, E., FALLON, J., LEDERMAN, M.M., LIEWEHR, D.J., SPRITZLER, J., STEINBERG, S.M., WOOD, L.V., YARCHOAN, R., ZUCKERMAN. J., LANDAY, A., and MACKALL, C.L. (2001). A potential role for interleukin-7 in T-cell homeostasis. Blood 97, 2983-2990.
25. GAENSSLEN, R.E., BERKA, K.M., GROSSO, D.A., RUANO, G., PAGLIARO, E.M., and MESS LEE, H.C. (1992). A polymerase chain reaction (PCR) method for sex and species determination with novel controls for deoxyribonucleic acid (DNA) template length. J. Forensic Sci. 37, 6-20.
26. GALOTTO, M., BERISSO, G., DELFINO, L., PODESTA, M., OTTAGGIO, L., DALLORSO, S., DUFOUR, C., KERRARA, G.B., ABBONDALOLO, A., DINI, G., BACIGALUPO, A., and CANCEDDA, R. (1999). Stromal damage as a consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp. Hematol. 27, 1460-1466.
27. GAZIT, D., TURGEMAN, G., KELLEY, P., WANG, E., JALENAK, M., ZILBERMAN, Y., and MOUTSATOS, I. (1999). Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J. Gene Med. 1, 121-133.
28. + T cells. J. Exp. Med. 194, 1711-1719.
29. GOUGOS, A., and LETARTE, M. (1988). Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J. Immunol. 141, 1925-1933.
30. + T cells. Eur. J. Immunol. 28, 3057-3065.
31. HERRMANN, H., and AEBI, U. (2000). Intermediate filaments and their associates: Multitalented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 12, 79-90.
32. JORGENSEN, C., DJOUAD, F., APPARAILLY, F., and NOEL, D. (2003). Engineering mesenchymal stem cells for immunotherapy. Gene Ther. 10, 928-931.
33. KIM, K., LEE, C.K., SAYERS, T.J., MUEGGE, K., and DURUM, S.K. (1998). The trophic action of IL-7 on pro-T cells: Inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J. Immunol. 160, 5735-5741.
34. KOMSCHLIES, K.L., GRZEGORZEWSKl K.J., and WILTROUT, R.H. (1995). Diverse immunological and hematological effects of interleukin 7: Implications for clinical application. J. Leukoc. Biol. 58, 623-633.
35. LEMISCHKA, I.R. (1997). Microenvironmental regulation of hematopoietic stem cells. Stem Cells 15, 63-68.
36. LEVY, R.B., JONES, M., HAMILTON, B.L., PAUPE, J., HOROWITZ, T., and RILEY, R. (1995). IL-7 drives donor T-cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J. Immunol. 154, 106-115.
37. LI, Y., HISHA, H., INABA, M., LIAN, Z., YU, C., KAWAMURA, M., YAMAMOTO, Y., NISHIO, N., TOKI, J., FAN, H., and IKEHARA, S. (2000). Evidence for inigration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp. Hematol. 28, 950-960.
38. MA, D.D., VARGA, D.E., and BIGGS, J.C. (1987). Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: Recovery of haemopoietic progenitors (CPU-Mix, BFU-E and CFU-GM). Br. J. Haematol. 65, 5-10.
39. MACKALL, C.L., FRY, T.J., BARE, C., MORGAN, P., GALBRAITH, A., and GRESS, R.E. (2001). IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97, 1491-1497.
40. MAITRA, B., SZEKELY, E., GJINI, K., LAUGHLIN, M.J., DENNIS, J., HAYNESWORTH, S.E., and KOC, O.N. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597-604.
41. MAJUMDAR, M.K., THIEDE, M.A., MOSCA, J.D., MOORMAN, M., and GERSON, S.L. (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchynial stem cells (MSCs) and stromal cells. J. Cell. Physiol. 176, 57-66.
42. MARSHALL, A.J., FLEMING, H.E., WU, G.E., and PAIGE, C.J. (1998). Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161, 6038-6045.
43. NAPOLITANO, L.A., GRANT, R.M., DEEKS, S.G., SCHMIDT, D., DE ROSA, S.C., HERZENBURG, L.A., HERNDIER, B.C., ANDERSSON, J., and MCCUNE, J.M. (2001). Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat. Med. 7, 73-79.
44. PEREBOEVA, L., KOMAROVA, S., MIKHEEVA. G., KRASNYKH, V., and CURIEL, D.T. (2003). Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells 21, 389-404.
45. PESCHON, J.J., MORRISSEY, P.J., GRABSTEIN, K.H., RAMSDELL, F.J., MARASKOVSKY, E., GLINIAK, B.C., PARK. L.S., ZIEGLER, S.F., WILLIAMS, D.E., and WARE, C.B. (1994). Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960.
46. + severe combined immunodeficiency. Nat. Genet. 20, 394-397.
47. RATHMELL, J.C., FARKASH, E.A., GAO, W., and THOMPSON, C.B. (2001). IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167, 6869-6876.
48. -, and week-6 CAFC assay predict poor engraftment. Exp. Hematol. 28, 1325-1333.
49. SALLUSTO, F., LENIG, D., FORSTER, R., LIPP, M., and LANZAVECCHIA, A. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712.
50. SCHLUNS, K.S., KIEPER, W.C., JAMESON, S.C., and LEFRANÇOIS, L. (2000). Interleukin-7 mediates the homeostasis of naive and memory CD8 T-cells in vivo. Nat. Immunol. 1, 426-432.
51. + T cells enables preservation of a naive repertoire. J. Immunol. 161, 5909-5917.
52. STEEPENS, C.M., MANAGLIA, E.Z., LANDAY, A., and ALHARTHI, L. (2002). Interleukin-7 treated naive T cells can be productively infected by T-cell-adapted and primary isolated of human immunodeficiency virus 1. Blood 99, 3310-3318.
53. + T cells, but affect their long-term life span. Immunity 5, 217-228.
54. TAN, J.T., DUDL, E., LEROY, E., MURRAY, R., SPRENT, J., WEINBERG, K.I., and SURTH, C.D. (2001). IL-7 is critical for homeostatic proliferation and survival of naive T-cells. Proc. Natl. Acad. Sci. U.S.A. 98, 8732-8737.
55. VARMUS, H. (1988). Retroviruses. Science 240, 1427-1435.
56. VERFAILLE, C.M. (1998). Adhesion receptors as regulators of the hematopoietic process. Blood 92, 2609-2612.
57. VON FREEDEN-JEFFRY, U., VIEIRA, P., LUCIAN, L.A., MCNEIL, T., BURDACH, S.E., and MURRAY, R. (1995). Lymphopenia in interleukin (IL-7)-gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
58. VON FREEDEN-JEFFRY, U., SOLVASON, N., HOWARD, M., and MURRAY, R. (1997). The earliest T lineage-commuted cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7, 147-154.
59. + T-cell pool. Immunology 98, 400-405.
60. WU, B.W., LU, J., GALLAHER, T.K., ANDERSON, W.F., and CANNON, P.M. (2000). Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin binding peptide. Virology 269, 7-17.